arrow
返回
C

Changhoon Yoo

university of ulsan

45H指数
461论文数
9.0K被引数
收录论文 182
发表时间
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial曲妥珠单抗联合纳武利尤单抗与吉西他滨和顺铂作为HER2阳性不可切除胆道癌的一线疗法:一项1b/2期临床试验
err2026-09-22
err0
errOAAI
errChoong-kun Lee; Taek Chung; Il Hwan Kim; Hong Jae Chon; Jin Won Kim; Se Jun Park; Woo Kyun Bae; Junghun Kang; Changhoon Yoo; Dong-Hoe Koo; Sora Kang; Minsuk Kwon; Ju Won Kim; Beodeul Kang; Sejung Park; Woochan Hwang; Chang Ho Ahn; Chang Gon Kim; Hye Jin Choi
err分享
err收藏
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy胆道癌患者接受化疗免疫疗法治疗后不良事件预测作用的全球人群研究
errCancers
IF4.4
err2026-09-10
err0
errOAAI
errLinda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa
err分享
err收藏
Molecular profiling of pancreatic acinar cell carcinoma and amphicrine-like carcinoma: high frequency of homologous recombination deficiency and molecular heterogeneity胰腺腺泡细胞癌和类混合分泌型癌的分子特征分析:同源重组缺陷高发及分子异质性
err2026-09-05
err0
PREAI
errChankyung Kim; Hyun-Nam Yun; Deokhoon Kim; Byung-Kwan Jeong; Jinho Shin; Changhoon Yoo; Dongwook Oh; Kyu-Pyo Kim; Tae Jun Song; Ki Byung Song; Seung Soo Lee; Song Cheol Kim; Seung-Mo Hong
err分享
err收藏
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial[177Lu]Lu-DOTA-TATE联合长效奥曲肽治疗新诊断的、进展期、2-3级胃肠胰腺神经内分泌肿瘤患者的疗效分析:来自随机III期NETTER-2试验的预先计划和事后分析
err2026-08-07
err0
errOAAI
errDiego Ferone; Marianne Pavel; Ken Herrmann; Pamela L. Kunz; Sten Myrehaug; Daniel Halperin; Beth Chasen; Jaume Capdevila; Amparo García-Burillo; Salvatore Tafuto; Secondo Lastoria; Do-Youn Oh; Changhoon Yoo; Stephen Falk; Thorvardur R. Halfdanarson; Maddalena Sansovini; Laura Gerard; Emmanuel Deshayes; Angelina Filice; Ilya Folitar
err分享
err收藏
Prognostic implications of tumour number in intrahepatic cholangiocarcinoma
err2026-01-29
err0
errOAAI
errBrandon Lok-Hang Chan; Yan Li; YoungJae Kim; Alex Chi-Fung Wong; Dorothy Cheuk-Yan Yiu; Landon Long Chan; Cheuk Man Chu; Changhoon Yoo; Hui-Chuan Sun; Stephen Lam Chan
err分享
err收藏
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic PotentialClaudin-18.2和Trop-2作为胆道肿瘤中新兴的生物标志物:表达分析及治疗潜力
err2025-12-28
err0
PREAI
errYeokyeong Shin; Jinho Shin; Hyehyun Jeong; Baek-Yeol Ryoo; Kyu-Pyo Kim; Inkeun Park; Dong-Wan Seo; Do Hyun Park; Tae Jun Song; Dongwook Oh; Dae Wook Hwang; Jae Hoon Lee; Ki Byung Song; Song Cheol Kim; Seung-Mo Hong; Changhoon Yoo
err分享
err收藏
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers度伐利尤单抗在晚期胆道癌中的应用:来自多个国际中心大型患者队列的真实世界数据
err2025-11-12
err0
errOAAI
errRimini, Margherita; Fornaro, Lorenzo; Ikeda, Masafumi; Abidoye, Oluseyi; Lucchetti, Jessica; Antonuzzo, Lorenzo; Kim, Jin Won; Nichetti, Federico; Saborowski, Anna; Pressiani, Tiziana; Vivaldi, Caterina; Rapposelli, Ilario Giovanni; Peeters, Frederik; Braconi, Chiara; Pinato, David J.; Tamburini, Emiliano; Pircher, Chiara; Tamberi, Stefano; Castet, Florian; Verrico, Monica; Parisi, Alessandro; Couto, Nuno; Chon, Hong Jae; Martirena, Andrea; Lamarca, Angela; Landriscina, Matteo; Fimkelmeier, Fabian; Oneda, Ester; Avallone, Antonio; Dell'Aquila, Emanuela; Perkhofer, Lukas; Kim, Il Hwan; Pinto, Cidalia Maria de Sousa; Garajova, Ingrid; Kang, Beodeul; Corallo, Salvatore; Fenocchio, Elisabetta; Farinea, Giovanni; Pastorino, Alessandro; Diana, Anna; Changhoon, Yoo; Schirripa, Marta; Rodriquenz, Maria Grazia; Scartozzi, Mario; Zumstein, Lucrezia; Ghidini, Michele; Prager, Gerald W.; Aprile, Giuseppe; Spinelli, Gian Paolo; Yung-Yeh, Su; Chan, Stephen; Warmington, Emily; Lancianese, Alessia; Bekaii-saab, Tanios; Lavacchi, Daniele; Kang, Minsu; Lonardi, Sara; Vogel, Arndt; Prete, Alessandra Anna; Bozzarelli, Silvia; Salani, Francesca; Persano, Mara; Masi, Gianluca; Balsano, Rita; Niger, Monica; Camera, Silvia; Passeri, Laura; Ferrara, Michele; Satake, Tomoyuki; Rimassa, Lorenza; Casadei-Gardini, Andrea
err分享
err收藏
Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab基因组通路改变及其在胆道癌中的预后影响:来自接受顺铂、吉西他滨和度伐利尤单抗治疗的跨国队列的见解
err2025-10-03
err0
PREAI
errChiara Pirrone; Umberto Malapelle; Francesco Pepe; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; Silvia Camera; Tomoyuki Satake; Frederik Peeters; Caterina Vivaldi; Tiziana Pressiani; Jessica Lucchetti; Jin Won Kim; Oluseyi Abidoye; Ilario Giovanni Rapposelli; Stefano Tamberi; Fabian Finkelmeier; Guido Giordano; Chiara Pircher; Hong Jae Chon; Chiara Braconi; Aitzaz Qaisar; Alessandro Pastorino; Florian Castet; Emiliano Tamburini; Changhoon Yoo; Alessandro Parisi; Anna Diana; Mario Scartozzi; Gerald W. Prager; Antonio Avallone; Salvatore Corallo; Marta Schirripa; Il Hwan Kim; Lukas Perkhofer; Ester Oneda; Monica Verrico; Jorge Adeva; Stephen L. Chan; Gian Paolo Spinelli; Nicola Personeni; Ingrid Garajova; Maria Grazia Rodriquenz; Silvana Leo; Cecilia Melo Alvim; Ricardo Roque; Giovanni Farinea; Francesca Salani; Caterina De Grandis; Daniele Lavacchi; Mara Persano; Masafumi Ikeda; Jeroen Dekervel; Monica Niger; Rita Balsano; Giuseppe Tonini; Minsu Kang; Tanios Bekaii-Saab; Luca Esposito; Alessandra Boccaccino; Vera Himmelsbach; Matteo Landriscina; Francesco De Cobelli; Francesca Ratti; Francesca Daniel; Giulia Tesini; Gianluca Masi; Arndt Vogel; Sara Lonardi; Margherita Rimini; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini
err分享
err收藏
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab多中心II期临床试验,评估仑伐替尼在经一线阿替利珠单抗联合贝伐珠单抗治疗后进展的晚期肝细胞癌患者中的应用。
err2025-09-04
err0
errOAAI
errHyung-Don Kim; Sun Jin Sym; Hong Jae Chon; Moonho Kim; Jung Hun Kang; Baek-Yeol Ryoo; Choong-kun Lee; Joohyun Hong; Hyewon Ryu; Woo Kyun Bae; Hyeyeong Kim; Hyunho Kim; Jin Won Kim; Tae-Yong Kim; Changhoon Yoo
err分享
err收藏
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population接受顺铂、吉西他滨和度伐利尤单抗治疗的晚期胆道癌患者中分子改变的影响:一项大型、真实世界、全球性人群研究
err2025-09-01
err1
PREAI
errRimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L.; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea
err分享
err收藏
err分享
err收藏
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population阿特珠单抗联合贝伐珠单抗与仑伐替尼对比用于巴塞罗那临床肝癌分期B期(BCLC-B)肝细胞癌(HCC)患者:一项真实世界人群研究
err2025-06-09
err0
PREAI
errFrancesco Vitiello; Toshifumi Tada; Goki Suda; Shigeo Shimose; Masatoshi Kudo; Jaekyung Cheon; Fabian Finkelmeier; Ho Yeong Lim; José Presa; Gianluca Masi; Changhoon Yoo; Sara Lonardi; Francesco Tovoli; Takashi Kumada; Mario Scartozzi; Emiliano Tamburini; Francesco Giuseppe Foschi; Mara Persano; Federico Rossari; Silvia Foti; Margherita Rimini
err分享
err收藏
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer候选替代终点与晚期胆道癌总生存率的关系
err2025-06-03
err0
PREAI
errFlorian Castet; Carles Fabregat-Franco; John Bridgewater; Jin Won Kim; Margherita Rimini; Adelaida La Casta; Angela Lamarca; Minsu Kang; Francesca Salani; Alfredo Castillo; Andre Lopes; Jaewon Hyung; Lorenza Rimassa; Jorge Adeva; Daniel López-Valbuena; Míriam Basagaña-Farres; Simran Vaja; Ka Man Mak; Tian V. Tian; Andrés Muñoz; Andrea Casadei-Gardini; Changhoon Yoo; Juan W. Valle; Teresa Macarulla
err分享
err收藏
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials脂质体伊立替康用于先前接受过治疗的患者胆道癌:NIFTY和NALIRICC试验的合并分析
err2025-03-25
err0
errOAAI
errChanghoon Yoo; Anna Saborowski; Jaewon Hyung; Patrick Wenzel; Ilhwan Kim; Henning Wege; Kyu-pyo Kim; Gunnar Folprecht; Baek-Yeol Ryoo; Phillip Schütt; Jaekyung Cheon; Thorsten Götze; Hyewon Ryu; Ji Sung Lee; Arndt Vogel
err分享
err收藏
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma接受阿特珠单抗-贝伐单抗治疗的肝细胞癌患者发生静脉曲张破裂出血的风险
err2025-01-28
err0
PREAI
errPark, Kanghee; Lee, Hye Won; Kim, Euichang; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Yoo, Changhoon; Ryoo, Baek-Yeol; Han, Seungbong; Choi, Jonggi
err分享
err收藏
A new prognostic index for patients with advanced biliary tract cancer treated with cisplatin, gemcitabine and durvalumab一种用于接受顺铂、吉西他滨和度伐利尤单抗治疗的晚期胆道癌患者的新型预后指数
err2024-12-01
err0
PREAI
errPersano, M.; Fornaro, L.; Antonuzzo, L.; Satake, T.; Vandeputte, H.; Lucchetti, J.; Kim, J. W.; Abidoye, O.; Rapposelli, I. G.; Tamberi, S.; Finkelmeier, F.; Giordano, G.; Nicchetti, F.; Chon, H. J.; Yoo, C.; Chan, S. L.; Scartozzi, M.; Lonardi, S.; Rimassa, L.; Gardini, A. Casadei
err分享
err收藏
KEYNOTE-966: 3-year follow-up for pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) vs placebo (pbo) plus gem/cis for patients (pts) with advanced biliary tract cancer (BTC)KEYNOTE-966: Pembrolizumab(pembro)联合吉西他滨和顺铂(gem/cis)对比安慰剂(pbo)联合吉西他滨和顺铂,用于晚期胆道癌(BTC)患者的3年随访研究。
err2024-12-01
err1
PREAI
errUeno, M.; Finn, R. S.; Yoo, C.; Ren, Z.; Furuse, J.; Kelley, R. K.; Chan, S. L.; Edeline, J.; Klumpen, H. J.; Yau, T.; Verslype, C.; Ozaka, M.; Bouattour, M.; Park, J. O.; Vogel, A.; Valle, J. W.; Starkopf, L.; Malhotra, U.; Siegel, A. B.; Qin, S.
err分享
err收藏
err分享
err收藏